Recent findings from the CDC reveal a troubling trend: drinking during pregnancy has increased since 2020, raising concerns about maternal and fetal health.
In recent biotech developments, Novartis has reaffirmed its focus on molecular glue strategies amidst rising drug costs for seniors and advancements in leukemia treatments.
Elizabeth Selvin reflects on the stark contrast in publication fees at Nature Medicine between 2025 and 2026, highlighting a significant financial burden for researchers.
A recent study by researchers at Skoltech, in collaboration with teams from the U.S. and China, sheds light on how anti-CRISPR proteins contribute to the spread of antibiotic resistance in Klebsiella pneumoniae.
The House Appropriations Committee has unveiled the FY 2027 appropriations bill for Labor, Health and Human Services, Education, and related agencies, highlighting global health funding.
A recent analysis highlights a troubling increase in drug shortages and pricing pressures in Europe, with U.S. authorities intensifying their scrutiny.
The Department of Justice has announced a second settlement concerning youth gender care, amidst broader health news including updates on sunscreen and leadership at NIAID.
As the U.S. observes the situation, European countries are developing varied approaches to drug pricing, which could have significant implications for the pharmaceutical sector and patient access.
This editorial examines how health care systems may affect native populations' views on immigration, particularly in light of rising anti-immigration sentiments globally.
A recent fact sheet outlines the important global health positions and officials within the U.S. government, highlighting their roles in health policy.
Wearable devices are increasingly generating substantial health data, yet much of it remains outside clinical settings. Recent initiatives by Oura and Whoop could potentially bridge this gap.
With at least 160 lives feared lost, health workers in DR Congo are battling a serious Ebola outbreak while navigating a complicated diplomatic situation with the EU.
A gene from wild maize has been found to increase protein content in crops, potentially aiding food security without affecting yields.
As agriculture becomes increasingly interconnected worldwide, the potential consequences of simultaneous failures in major food-producing regions could be significant.
Novo Nordisk expresses disappointment with a drug it previously contested with Pfizer. Meanwhile, Revolution and Tango show encouraging cancer results, and Incyte acquires a bleeding disorder treatment.
Lilly has released additional data regarding the safety and tolerability of its obesity drug retatrutide, contributing to ongoing discussions in the pharmaceutical sector.
The annual diabetes conference has provided significant insights, including discussions on "Schedule F" and the response to the Ebola outbreak, among other health topics.
A unique program at Massachusetts General Hospital aims to address the vascular health needs of unhoused patients, potentially preventing limb loss.
Recent findings suggest that while Boehringer Ingelheim’s obesity drug may effectively reduce liver fat, its overall weight loss results are less compelling.
The American Diabetes Association's annual conference in New Orleans showcased new insights, including developments in hormone receptors and a monthly obesity drug.